batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
Meningococcal Meningitis
pharma · Tuberculosis · Meningococcal Meningitis
CanSino Biologics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Registry index of 3 ClinicalTrials.gov studies linked to CanSino Biologics programs — each row shows trial ID, program name, phase, status, and indication.
CanSino Biologics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Latest clinical program signals indexed for CanSino Biologics.
Meningococcal Meningitis